Similar articles for PMID: 12746848

Year	Number of Results
1983	2
1984	1
1985	1
1989	1
1991	1
1993	1
1994	1
1995	1
1996	5
1997	7
1998	8
1999	16
2000	14
2001	12
2002	11
2003	14
2004	13
2005	11
2006	16
2007	10
2008	9
2009	3
2010	1
2011	1
2012	1
2013	1
2015	1
2016	1
2018	1
2019	1
2020	3
2023	1
2024	0

1

Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapy.

Parkinson RJ, Mian S, Bishop MC, Gray T, Li G, McArdle SE, Ali S, Rees RC. Parkinson RJ, et al. Prostate. 2003 Jun 15;56(1):65-73. doi: 10.1002/pros.10207. Prostate. 2003. PMID: 12746848

2

Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.

Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC. Ali SA, et al. Cancer Res. 2000 Mar 15;60(6):1663-70. Cancer Res. 2000. PMID: 10749137

3

Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.

Kim SH, Carew JF, Kooby DA, Shields J, Entwisle C, Patel S, Shah JP, Fong Y. Kim SH, et al. Cancer Gene Ther. 2000 Sep;7(9):1279-85. doi: 10.1038/sj.cgt.7700231. Cancer Gene Ther. 2000. PMID: 11023201

4

Disabled infectious single-cycle herpes simplex virus as an oncolytic vector for immunotherapy of colorectal cancer.

Todryk S, McLean C, Ali S, Entwistle C, Boursnell M, Rees R, Vile R. Todryk S, et al. Hum Gene Ther. 1999 Nov 20;10(17):2757-68. doi: 10.1089/10430349950016492. Hum Gene Ther. 1999. PMID: 10584922

5

Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.

Guan J, Ma L, Wei L. Guan J, et al. Chin Med J (Engl). 2001 Feb;114(2):147-51. Chin Med J (Engl). 2001. PMID: 11780195

6

Preclinical evaluation of DISC-GMCSF for the treatment of breast carcinoma.

Loudon PT, McLean CS, Martin G, Curry J, Leigh Shaw M, Hoogstraten C, Verdegaal E, Osanto S. Loudon PT, et al. J Gene Med. 2003 May;5(5):407-16. doi: 10.1002/jgm.354. J Gene Med. 2003. PMID: 12731089

7

Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.

Toda M, Martuza RL, Rabkin SD. Toda M, et al. Mol Ther. 2000 Oct;2(4):324-9. doi: 10.1006/mthe.2000.0130. Mol Ther. 2000. PMID: 11020347 Free article.

8

Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines.

Withoff S, Glazenburg KL, van Veen ML, Kraak MM, Hospers GA, Störkel S, de Vries EG, Wilschut J, Daemen T. Withoff S, et al. Gene Ther. 2001 Oct;8(20):1515-23. doi: 10.1038/sj.gt.3301556. Gene Ther. 2001. PMID: 11704811

9

Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus.

Kohno SI, Luo C, Nawa A, Fujimoto Y, Watanabe D, Goshima F, Tsurumi T, Nishiyama Y. Kohno SI, et al. Cancer Gene Ther. 2007 Nov;14(11):918-26. doi: 10.1038/sj.cgt.7701070. Epub 2007 Aug 10. Cancer Gene Ther. 2007. PMID: 17693992

10

ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties.

Liu BL, Robinson M, Han ZQ, Branston RH, English C, Reay P, McGrath Y, Thomas SK, Thornton M, Bullock P, Love CA, Coffin RS. Liu BL, et al. Gene Ther. 2003 Feb;10(4):292-303. doi: 10.1038/sj.gt.3301885. Gene Ther. 2003. PMID: 12595888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

164 results

Results by year